| 1 | [SID26664392] | Active | AC50 | 0.246 | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_Dose_CherryPick_Activity [AID504725, Type: confirmatory] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | AC50 | 0.246 [uM] | | BioAssay | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_Dose_CherryPick_Activity | | AID | 504725 | | BioAssay type | confirmatory | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 2 | [SID26664392] | Active | AC50 | 0.342 | C-LANA Counter Screen: DNA intercalators Measured in Biochemical System Using Plate Reader - 2117-02_Inhibitor_Dose_CherryPick_Activity_Set2 [AID504727, Type: confirmatory] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | AC50 | 0.342 [uM] | | BioAssay | C-LANA Counter Screen: DNA intercalators Measured in Biochemical System Using Plate Reader - 2117-02_Inhibitor_Dose_CherryPick_Activity_Set2 | | AID | 504727 | | BioAssay type | confirmatory | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 3 | [SID26664392] | Active | Potency | 0.919 | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation [AID651600, Type: confirmatory] | TSG101 gene product [Homo sapiens] [gi:5454140] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | Potency | 0.919 [uM] | | BioAssay | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation | | AID | 651600 | | BioAssay type | confirmatory | | Target | TSG101 gene product [Homo sapiens] [gi:5454140] | | PubMed | | | Data Table |  |
|
| 4 | [SID26664392] | Active | Potency | 0.919 | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation [AID651600, Type: confirmatory] | TSG101 gene product [Homo sapiens] [gi:5454140] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | Potency | 0.919 [uM] | | BioAssay | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation | | AID | 651600 | | BioAssay type | confirmatory | | Target | TSG101 gene product [Homo sapiens] [gi:5454140] | | PubMed | | | Data Table |  |
|
| 5 | [SID26664392] | Active | Potency | 1.7852 | qHTS Fluorescence Polarization (FP) Assay for Inhibitors of MLL CXXC domain - DNA interaction: Fluorescein FP [AID624160, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | Potency | 1.7852 [uM] | | BioAssay | qHTS Fluorescence Polarization (FP) Assay for Inhibitors of MLL CXXC domain - DNA interaction: Fluorescein FP | | AID | 624160 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID26664392] | Active | Potency | 2.8184 | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) [AID2147, Type: confirmatory] | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | Potency | 2.8184 [uM] | | BioAssay | qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E) | | AID | 2147 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of The Human 2-Oxoglutarate Oxygenase Loc390245 [gi:221046486] | | PubMed | | | Data Table |  |
|
| 7 | [SID26664392] | Active | Potency | 3.5481 | qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1) [AID485290, Type: confirmatory] | Chain A, Crystal Structure Of Human Tyrosyl-Dna Phosphodiesterase (Tdp1) [gi:20150581] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | Potency | 3.5481 [uM] | | BioAssay | qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1) | | AID | 485290 | | BioAssay type | confirmatory | | Target | Chain A, Crystal Structure Of Human Tyrosyl-Dna Phosphodiesterase (Tdp1) [gi:20150581] | | PubMed | | | Data Table |  |
|
| 8 | [SID26664392] | Active | IC50 | 18.76 | Dose Response Confirmation for Mcl-1/Bid Interaction Inhibitors [AID1418, Type: confirmatory] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | IC50 | 18.76 [uM] | | BioAssay | Dose Response Confirmation for Mcl-1/Bid Interaction Inhibitors | | AID | 1418 | | BioAssay type | confirmatory | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 9 | [SID26664392] | Active | IC50 | 18.76 | Dose Response Confirmation for Mcl-1/Bid Interaction Inhibitors [AID1418, Type: confirmatory] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | IC50 | 18.76 [uM] | | BioAssay | Dose Response Confirmation for Mcl-1/Bid Interaction Inhibitors | | AID | 1418 | | BioAssay type | confirmatory | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 10 | [SID26664392] | Active | IC50 | 18.76 | Dose Response Confirmation for Mcl-1/Bid Interaction Inhibitors [AID1418, Type: confirmatory] | Mcl-1 [Homo sapiens] [gi:7582271] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | IC50 | 18.76 [uM] | | BioAssay | Dose Response Confirmation for Mcl-1/Bid Interaction Inhibitors | | AID | 1418 | | BioAssay type | confirmatory | | Target | Mcl-1 [Homo sapiens] [gi:7582271] | | PubMed | | | Data Table |  |
|
| 11 | [SID26664392] | Active | Potency | 35.4813 | qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction [AID624246, Type: confirmatory] | ERG gene product [Homo sapiens] [gi:343478176] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction | | AID | 624246 | | BioAssay type | confirmatory | | Target | ERG gene product [Homo sapiens] [gi:343478176] | | PubMed | | | Data Table |  |
|
| 12 | [SID26664392] | Active | Potency | 35.4813 | qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction [AID624246, Type: confirmatory] | ERG gene product [Homo sapiens] [gi:343478176] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction | | AID | 624246 | | BioAssay type | confirmatory | | Target | ERG gene product [Homo sapiens] [gi:343478176] | | PubMed | | | Data Table |  |
|
| 13 | [SID26664392] | Active | | | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex [AID588473, Type: screening] | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex | | AID | 588473 | | BioAssay type | screening | | Target | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] | | PubMed | | | Data Table |  |
|
| 14 | [SID26664392] | Active | | | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex [AID588473, Type: screening] | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex | | AID | 588473 | | BioAssay type | screening | | Target | corticotropin releasing factor-binding protein [Homo sapiens] [gi:30219] | | PubMed | | | Data Table |  |
|
| 15 | [SID26664392] | Active | | | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID588458, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 588458 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 16 | [SID26664392] | Active | | | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID588458, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 588458 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 17 | [SID26664392] | Active | | | Single concentration confirmation of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID602385, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | Single concentration confirmation of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 602385 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 18 | [SID26664392] | Active | | | Single concentration confirmation of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID602385, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | Single concentration confirmation of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 602385 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 19 | [SID26664392] | Active | | | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists [AID485358, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists | | AID | 485358 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 20 | [SID26664392] | Active | | | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists [AID485358, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists | | AID | 485358 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 21 | [SID26664392] | Active | | | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists [AID485358, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists | | AID | 485358 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 22 | [SID26664392] | Active | | | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists [AID485358, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists | | AID | 485358 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 23 | [SID26664392] | Active | | | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists [AID485358, Type: screening] | DRD2 gene product [Homo sapiens] [gi:4503385] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | HTS Assay for Allosteric Agonists of the Human D2 Dopamine Receptor: Primary Screen for Agonists | | AID | 485358 | | BioAssay type | screening | | Target | DRD2 gene product [Homo sapiens] [gi:4503385] | | PubMed | | | Data Table |  |
|
| 24 | [SID26664392] | Active | | | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity [AID504423, Type: screening] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504423 | | BioAssay type | screening | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 25 | [SID26664392] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 26 | [SID26664392] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 27 | [SID26664392] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1) [AID588814, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1) | | AID | 588814 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 28 | [SID26664392] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1) [AID588814, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1) | | AID | 588814 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 29 | [SID26664392] | Active | | | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set [AID588497, Type: Literature] | botulinum neurotoxin type F, BoNT/F [Clostridium botulinum Bf] [gi:168184763] |   View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | | AID | 588497 | | BioAssay type | Literature | | Target | botulinum neurotoxin type F, BoNT/F [Clostridium botulinum Bf] [gi:168184763] | | PubMed | 16604538 | | Data Table |  |
|
| 30 | [SID26664392] | Active | | | Single concentration validation of uHTS inhibitor hits from DNMT1 for spectral interference using a Fluorescent Molecular Beacon assay [AID602387, Type: screening] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | Single concentration validation of uHTS inhibitor hits from DNMT1 for spectral interference using a Fluorescent Molecular Beacon assay | | AID | 602387 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID26664392] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624127, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624127 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 32 | [SID26664392] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624127, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624127 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 33 | [SID26664392] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624127, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624127 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 34 | [SID26664392] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 35 | [SID26664392] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 36 | [SID26664392] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 37 | [SID26664392] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 38 | [SID26664392] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 39 | [SID26664392] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 40 | [SID26664392] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) [AID624125, Type: screening] | CHRM4 gene product [Homo sapiens] [gi:52426748] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4) | | AID | 624125 | | BioAssay type | screening | | Target | CHRM4 gene product [Homo sapiens] [gi:52426748] | | PubMed | | | Data Table |  |
|
| 41 | [SID26664392] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 42 | [SID26664392] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 43 | [SID26664392] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 44 | [SID26664392] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624040, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624040 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 45 | [SID26664392] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 46 | [SID26664392] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 47 | [SID26664392] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 48 | [SID26664392] | Active | | | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS [AID504660, Type: screening] | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | Allosteric Agonists of the Human D1 Dopamine Receptor: qHTS | | AID | 504660 | | BioAssay type | screening | | Target | D(1A) dopamine receptor [Homo sapiens] [gi:4503383] | | PubMed | | | Data Table |  |
|
| 49 | [SID26664392] | Active | | | Epi-absorbance-based confirmation assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase. [AID2189, Type: screening] | metallo-beta-lactamase IMP-1 [Pseudomonas aeruginosa] [gi:27368096] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | Epi-absorbance-based confirmation assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase. | | AID | 2189 | | BioAssay type | screening | | Target | metallo-beta-lactamase IMP-1 [Pseudomonas aeruginosa] [gi:27368096] | | PubMed | | | Data Table |  |
|
| 50 | [SID26664392] | Active | | | Epi-absorbance primary biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase [AID1556, Type: screening] | metallo-beta-lactamase IMP-1 [Pseudomonas aeruginosa] [gi:27368096] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26664392 | | CID | 22641 | | Outcome | Active | | BioAssay | Epi-absorbance primary biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase | | AID | 1556 | | BioAssay type | screening | | Target | metallo-beta-lactamase IMP-1 [Pseudomonas aeruginosa] [gi:27368096] | | PubMed | | | Data Table |  |
|